MET receptor sequence variants R970C and T992I lack transforming capacity.
about
Dysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistanceBiology of MET: a double life between normal tissue repair and tumor progressionActivating mutation in MET oncogene in familial colorectal cancer.The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in CancerOncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis.Prospective enterprise-level molecular genotyping of a cohort of cancer patients.Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registryMET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell linesFunctional consequence of the MET-T1010I polymorphism in breast cancerRetrospective Review of MET Gene Mutations.Autism Linked to Increased Oncogene Mutations but Decreased Cancer Rate.Biological properties of ligand-dependent activation of the MET receptor kinase in acute myeloid leukemia.SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer.A molecular case report: functional assay of tyrosine kinase inhibitors in cells from a patient's primary renal cell carcinoma.Targeting the HGF/Met signaling pathway in cancer therapyBeside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets.c-Met expression and activity in urogenital cancers - novel aspects of signal transduction and medical implications.MET receptor variant R970C favors calpain-dependent generation of a fragment promoting epithelial cell scattering.Genetically informed lung cancer medicine.c-MET as a potential therapeutic target and biomarker in cancer.Developing biomarkers to predict benefit from HGF/MET pathway inhibitors.The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?MET and Small-Cell Lung Cancer.cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance.Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers.Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer.Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas.Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer.MET T992I mutation in a case of ependymoblastoma/embryonal tumour with multilayered rosettes.Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients.Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.Single-nucleotide polymorphism rs41736 located in MET was significantly associated with prognosis of small cell lung cancer patients.
P2860
Q26799900-56E5EEA6-89D9-426A-B6B5-0F6E56BD28B1Q28085247-43FAB75F-8189-4F77-957A-EBDB0F2169E9Q34039577-7B1E82AB-FA1E-426D-B79C-D15547E15B38Q34141913-72E80614-603A-47D1-8F1A-97B6597E712DQ34402363-90B666C1-68BD-4004-BFC6-FB643E239457Q34409739-A581C242-2764-498D-9DBC-209E56E6F89AQ35169273-83C0D50E-D22A-482A-B873-526A02B46BC9Q35208173-70961B7C-5957-4506-8D6C-7CB62208C69BQ35550045-6538091E-5969-448B-A74C-29747019320EQ35745037-55AB697E-9788-4FA3-A362-4DA3E2EEA2C6Q35943062-AC64FF5E-1C49-4D76-8E6C-EB725721EEB0Q36263622-F8453634-1552-4F72-842F-3599CB8A3302Q36346565-59C1D642-91C9-4E39-9CC2-37CFE3F8B2AFQ36608758-3265CE05-49ED-437B-926A-CFA6906488B5Q37013777-80CCE388-CC66-4DD2-9291-3FC84546A844Q37406889-FE147835-B9D5-4B63-888E-6B5A658FA47EQ37651008-9F762ABA-3CF7-42B7-BE88-7DF91DE226D8Q37706900-46223500-2F26-4AE2-8A7A-8866F2287C2DQ37815136-BA1E6A81-63A2-45D7-9DCC-5D02A3CCC25AQ37962905-D9F7E075-1B4F-480B-89C1-51836596B613Q38150768-31C53F2C-1568-4B5E-B6C3-FEFB779D2039Q38239580-7EE0D586-263C-4AC7-8554-55EC115D31A0Q38260120-BDF5C0F0-78C3-4464-94AC-C1C329B95DE9Q38393333-484C36A8-AAFB-4F5B-B1FA-8BC9D4617B5EQ38735120-0520FE96-D83C-4FB4-84E4-EC70BBB5AEA7Q39449489-EE6DF115-570E-428C-B7D9-4998CEE486B3Q41636404-843DA0BD-CCB1-4133-A00A-2F52E49274AAQ46836891-A086D3D7-FAEB-44F2-967E-1FECA071D327Q47400935-CB7CA263-E44C-44FE-9884-0D52FD376DF1Q48561269-5FD3D951-8D1A-4E26-A555-6C6286C7AD02Q50351356-86FE9260-C61F-420E-8D23-9DC53E267400Q52312700-B7F78108-91F6-49BA-B6E1-B066C148C930Q55070113-03B6F619-8C02-47A4-9298-F74C9A147115
P2860
MET receptor sequence variants R970C and T992I lack transforming capacity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
MET receptor sequence variants R970C and T992I lack transforming capacity.
@ast
MET receptor sequence variants R970C and T992I lack transforming capacity.
@en
MET receptor sequence variants R970C and T992I lack transforming capacity.
@nl
type
label
MET receptor sequence variants R970C and T992I lack transforming capacity.
@ast
MET receptor sequence variants R970C and T992I lack transforming capacity.
@en
MET receptor sequence variants R970C and T992I lack transforming capacity.
@nl
prefLabel
MET receptor sequence variants R970C and T992I lack transforming capacity.
@ast
MET receptor sequence variants R970C and T992I lack transforming capacity.
@en
MET receptor sequence variants R970C and T992I lack transforming capacity.
@nl
P2093
P2860
P50
P1433
P1476
MET receptor sequence variants R970C and T992I lack transforming capacity.
@en
P2093
Carol Beadling
Ellen Q Wang
Luke B Fletcher
Marc M Loriaux
Michael L Rutenberg-Schoenberg
Michael W Deininger
Motomi Mori
Wayne F Yang
P2860
P304
P356
10.1158/0008-5472.CAN-10-0429
P407
P577
2010-08-01T00:00:00Z